U.S. RESEARCH ROUNDUP Azek Company, Galera Therapeutics, Vivint Smart Home

1 minute read
Register now for FREE unlimited access to Reuters.com

Dec 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Azek Company, Galera Therapeutics and Vivint Smart Home, on Wednesday.

HIGHLIGHTS

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

Register now for FREE unlimited access to Reuters.com
Compiled by Bengaluru Newsroom

Our Standards: The Thomson Reuters Trust Principles.